epidemiology
aminoglycoside-induced nephrotoxicity
Experimental studies
healthy
human
volunteers
aminoglycosides
proximal
tubular damage
patients
glomerular
tubular dysfunction
Clinical trials
aminoglycosides
ill
patients
relative risk
acute renal failure
therapy
risk
analysis
data
duration
therapy
plasma
aminoglycoside
levels
liver disease
advanced age
creatinine clearance
female
gender
increase
risk
nephrotoxicity
acute renal failure
shock
additive effect
Predictive models
analyses
patients
high risk
models
pathophysiology
aminoglycoside-induced nephrotoxicity
